{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:53:02Z","timestamp":1772819582436,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre of Poland","doi-asserted-by":"crossref","award":["UMO-2011\/01\/B\/NZ4\/01581"],"award-info":[{"award-number":["UMO-2011\/01\/B\/NZ4\/01581"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.pharep.2016.09.022","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T11:01:06Z","timestamp":1475233266000},"page":"29-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Contribution of the nitric oxide donor molsidomine and the antiparkinsonian drug l-DOPA to the modulation of the blood pressure in unilaterally 6-OHDA-lesioned rats"],"prefix":"10.1007","volume":"69","author":[{"given":"El\u017cbieta","family":"Lorenc-Koci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Czarnecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinga","family":"Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Knutelska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Zygmunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"1","key":"10.1016\/j.pharep.2016.09.022_bib0005","first-page":"343","article-title":"A central nervous system action of nitric oxide in blood pressure regulation","volume":"262","author":"Togashi","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"issue":"4 Pt 2","key":"10.1016\/j.pharep.2016.09.022_bib0010","first-page":"R958","article-title":"Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide","volume":"268","author":"Zanzinger","year":"1995","journal-title":"Am J Physiol"},{"issue":"1 Pt 2","key":"10.1016\/j.pharep.2016.09.022_bib0015","first-page":"R306","article-title":"Nitric oxide actions in paraventricular nucleus: cardiovascular and neurochemical implications","volume":"266","author":"Horn","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharep.2016.09.022_bib0020","first-page":"6","article-title":"Involvement of the medial prefrontal cortex in central cardiovascular modulation in the rat","volume":"12","author":"Resstel","year":"2006","journal-title":"Auton Neurosci"},{"issue":"1","key":"10.1016\/j.pharep.2016.09.022_bib0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuropharm.2006.03.010","article-title":"Injection of l-glutamate into medial prefrontal cortex induces cardiovascular responses through NMDA receptor\u2014nitric oxide in rat","volume":"51","author":"Resstel","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2016.09.022_bib0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brainres.2010.05.023","article-title":"Cardiovascular responses to L-glutamate microinjection into the hypothalamic paraventricular nucleus are mediated by a local nitric oxide-guanylate cyclase mechanism","volume":"1344","author":"Busnardo","year":"2010","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pharep.2016.09.022_bib0035","first-page":"303","article-title":"Central effects of quinpirole on blood pressure of spontaneously hypertensive rats","volume":"262","author":"van den Buuse","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"issue":"6 Pt 2","key":"10.1016\/j.pharep.2016.09.022_bib0040","first-page":"H2489","article-title":"Stimulation of the nigrostriatal dopamine system produces hypertension and tachycardia in rats","volume":"266","author":"Lin","year":"1994","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1016\/j.pharep.2016.09.022_bib0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0304-3940(94)90068-X","article-title":"Pressor responses to electrical and chemical stimulation of the rat brain A10 dopaminergic system","volume":"176","author":"Cornish","year":"1994","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.pharep.2016.09.022_bib0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02260966","article-title":"NADPH-diaphorase\/nitric oxide synthase containing neurons in normal and Parkinson\u2019s disease putamen","volume":"7","author":"B\u00f6ckelmann","year":"1994","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"1","key":"10.1016\/j.pharep.2016.09.022_bib0055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0169-328X(98)00259-9","article-title":"Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson\u2019s disease","volume":"63","author":"Eve","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"10.1016\/j.pharep.2016.09.022_bib0060","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1460-9568.2000.00927.x","article-title":"NO-mediated cGMP synthesis in cholinergic neurons in the rat forebrain: effects of lesioning dopaminergic or serotonergic pathways on nNOS and cGMP synthesis","volume":"12","author":"de Vente","year":"2000","journal-title":"Eur J Neurosci"},{"issue":"4","key":"10.1016\/j.pharep.2016.09.022_bib0065","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1460-9568.2004.03566.x","article-title":"Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation","volume":"20","author":"Sancesario","year":"2004","journal-title":"Eur J Neurosci"},{"issue":"7","key":"10.1016\/j.pharep.2016.09.022_bib0070","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2174\/187152711798072329","article-title":"Nitric oxide modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders","volume":"10","author":"Pierucci","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"10.1016\/j.pharep.2016.09.022_bib0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0022-510X(94)90155-4","article-title":"Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer\u2019s disease and multiple system atrophy patients","volume":"121","author":"Kuiper","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.pharep.2016.09.022_bib0080","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2013.10.011","article-title":"Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: the effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine","volume":"1541","author":"Czarnecka","year":"2013","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.pharep.2016.09.022_bib0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.npp.1300826","article-title":"Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1\/5) receptor-dependent mechanism","volume":"31","author":"Sammut","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharep.2016.09.022_bib0090","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00213-006-0681-z","article-title":"Dopamine D2 receptor-dependent modulation of striatal NO synthase activity","volume":"191","author":"Sammut","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.pharep.2016.09.022_bib0095","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1471-4159.2009.06416.x","article-title":"Regulation of striatal nitric oxide synthesis by local dopamine and glutamate interactions","volume":"111","author":"Park","year":"2009","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.pharep.2016.09.022_bib0100","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00213-009-1687-0","article-title":"Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity","volume":"207","author":"Hoque","year":"2010","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pharep.2016.09.022_bib0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","article-title":"The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease","volume":"65","author":"Huot","year":"2013","journal-title":"Pharmacol Rev"},{"issue":"8","key":"10.1016\/j.pharep.2016.09.022_bib0110","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.neuint.2013.09.021","article-title":"Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA","volume":"63","author":"Lorenc-Koci","year":"2013","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharep.2016.09.022_bib0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2014.09.010","article-title":"Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-\/-) aphakia mice","volume":"73","author":"Sol\u00eds","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"8","key":"10.1016\/j.pharep.2016.09.022_bib0120","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1586\/14737175.6.8.1173","article-title":"Blood pressure disorders during Parkinson's disease: epidemiology, pathophysiology and management","volume":"6","author":"Pathak","year":"2006","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"10.1016\/j.pharep.2016.09.022_bib0125","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nbd.2011.10.025","article-title":"Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis","volume":"46","author":"Jain","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.pharep.2016.09.022_bib0130","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/01.HYP.0000188052.69549.e4","article-title":"Neurocirculatory abnormalities in Parkinson\u2019s disease with orthostatic hypotension: independence from levodopa treatment","volume":"46","author":"Goldstein","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharep.2016.09.022_bib0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2009.08.031","article-title":"Cardiovascular autonomic dysfunction in Parkinson\u2019s disease","volume":"289","author":"Ziemssen","year":"2010","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.pharep.2016.09.022_bib0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(76)90352-6","article-title":"Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats","volume":"40","author":"Kelly","year":"1976","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2016.09.022_bib0145","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.pharep.2016.09.022_bib0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol Scand Suppl"},{"issue":"2","key":"10.1016\/j.pharep.2016.09.022_bib0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway","volume":"75","author":"Deumens","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharep.2016.09.022_bib0160","article-title":"Subtle cardiovascular dysfunction in the unilateral 6-hdroxydopamine-lesioned rats","volume":"427810","author":"Slack","year":"2010","journal-title":"Parkinsons Dis"},{"issue":"Supp 2","key":"10.1016\/j.pharep.2016.09.022_bib0165","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/S1353-8020(11)70850-1","article-title":"Neurochemical and behavioral changes corresponding to the advanced Parkinson\u2019s disease with coexistent depresion in rats treated unilaterally with 6-OHDA","volume":"18","author":"Lorenc-Koci","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.pharep.2016.09.022_bib0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"issue":"2","key":"10.1016\/j.pharep.2016.09.022_bib0175","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1113\/expphysiol.2004.029041","article-title":"A role for the paraventricular nucleus of the hypothalamus in the autonomic control of heart and kidney","volume":"90","author":"Coote","year":"2005","journal-title":"Exp Physiol"},{"issue":"10","key":"10.1016\/j.pharep.2016.09.022_bib0180","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s000180050371","article-title":"General anaesthetic actions on ligand-gated ion channels","volume":"55","author":"Krasowski","year":"1999","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.pharep.2016.09.022_bib0185","doi-asserted-by":"crossref","first-page":"H250","DOI":"10.1152\/ajpheart.00406.2014","article-title":"Dysautonomias in Parkinson\u2019s disease: cardiovascular changes and autonomic modulation in conscious rats after infusion of bilateral 6-OHDA in substantia nigra","volume":"308","author":"Ariza","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.pharep.2016.09.022_bib0190","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neulet.2011.06.025","article-title":"Blood pressure increased dramatically in hypertensive rats after left hemisphere lesions with 6-hydroxydopamine","volume":"500","author":"Banegas","year":"2011","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2016.09.022_bib0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02250917","article-title":"The role of excitatory amino acids in experimental models of Parkinson's disease","volume":"8","author":"Ossowska","year":"1994","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"5","key":"10.1016\/j.pharep.2016.09.022_bib0200","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10072-012-1251-2","article-title":"Arterial hypertension, a tricky side of Parkinson\u2019s disease: physiopathology and therapeutic features","volume":"34","author":"Mazza","year":"2013","journal-title":"Neurol Sci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016302201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016302201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:43Z","timestamp":1752611803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2016.09.022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1734114016302201"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2016.09.022","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of the nitric oxide donor molsidomine and the antiparkinsonian drug l-DOPA to the modulation of the blood pressure in unilaterally 6-OHDA-lesioned rats","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2016.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}